Oppenheimer cuts Acadia Pharmaceuticals’ target price to $23 from $25
ACAD•Oppenheimer cut its target price for Acadia Pharmaceuticals to $23 from $25.
Related News
When Treasuries catch Korea's volatility bug, take cover
TLT•
Lionsgate Studios Corp.: JPMorgan initiates coverage with underweight rating; price target $9
LION•
CBOT corn may bounce into $5.21-3/4 to $5.24-1/4 range
CORN•
StandardAero: Jefferies cuts target price to $25 from $30
SARO•
What is 'Taiwan independence' and is Taiwan already independent?
EWT•